BTIG Starts Matinas BioPharma Holdings Inc. (MTNB) at Buy, Sees Material Potential for MAT9001
Tweet Send to a Friend
BTIG analyst Robert Hazlett initiates coverage on Matinas BioPharma Holdings Inc. (NYSE: MTNB) with a Buy rating and a price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE